Internal: Archive

CDS panel: Credit Suisse AT1 wipeout won’t prompt payout

This content was published on May 18, 2023 A panel tasked with overseeing the credit default swaps market says the write-down of Credit Suisse AT1 bonds will not trigger an insurance payout.

Marco Sieber in an astronaut training suit in front of a 1:1 model of an ISS module. The Swiss flag prominently on his shoulder

Swiss astronaut: ‘Money for space travel is an investment’

This content was published on May 18, 2023 Marco Sieber is the second Swiss astronaut after Claude Nicollier. We met him at the ESA training centre in Cologne, Germany.

Alpine solar farms set for public vote in canton Valais

This content was published on May 17, 2023 Voters in canton Valais in southern Switzerland are likely to have the final say on the construction of large solar parks in high-mountain regions.

The quarter billion dollar bet on a crypto revival

This content was published on May 17, 2023 Just as cryptocurrency investors are rushing to the exit, Ripple buys Swiss crypto storage firm Metaco for $250 million.

Expert group to study role of banks in Switzerland

This content was published on May 17, 2023 The Swiss finance ministry has set up an expert group to study the role of banks and too-big-to-fail regulations in Switzerland.

Swiss regulator shuts down rogue crypto school

This content was published on May 17, 2023 The 'Dohrnii' cryptocurrency scheme, purportedly set up for educational purposes, has been shut down by Swiss regulators having “seriously violated supervisory law”.

CHF1,000 notes account for half of all Swiss cash

This content was published on May 17, 2023 More than half of all Swiss cash in circulation, almost CHF50 billion, is held in CHF1,000 notes.

Some 134 anti-LGBTQ attacks registered in 2022

This content was published on May 17, 2023 Reported discrimination reached record levels in 2022, but unreported cases mean the true extent is difficult to assess, rights groups said on Wednesday.

Swiss start-up sets out to lower cost of gene therapy

This content was published on May 17, 2023 Swiss start-up NewBiologix is one of a growing number of companies setting up shop in Switzerland to meet the demands of gene and cell therapy makers.

UBS set for $35 billion short-term gain from Credit Suisse deal

This content was published on May 17, 2023 UBS is set for a one-off accounting gain as a result of the merger, but financial hits – including due to legal cases – are looming.

Page 272 of 2840

First … 270 271 272 273 274 … Last

Internal: Archive

Popular Stories

Most Discussed

Sign in and personalize Swissinfo